JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB263348

Human SLC12A9 knockout HeLa cell lysate

Be the first to review this product! Submit a review

|

(0 Publication)

SLC12A9 KO cell lysate available now. KO validated by. Free of charge wild type control included. Knockout achieved by using CRISPR/Cas9, 1 bp deletion in exon2.

View Alternative Names

CCC-interacting protein 1, Cation-chloride cotransporter 6, Cation-chloride cotransporter-interacting protein 1, Potassium-chloride transporter 9, S12A9_HUMAN, SLC12A9, Solute carrier family 12 member 9, WO3.3, hCCC6, hCIP1

1 Images
Sanger Sequencing - Human SLC12A9 knockout HeLa cell lysate (AB263348)
  • Sanger seq

Unknown

Sanger Sequencing - Human SLC12A9 knockout HeLa cell lysate (AB263348)

Homozygous : 1 bp deletion in exon2

Key facts

Cell type

HeLa

Species or organism

Human

Tissue

Cervix

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, 1 bp deletion in exon2.

Disease

Adenocarcinoma

Product details

Knockout cell lysate achieved by CRISPR/Cas9.

REACH authorisation
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.

Lysate preparation: Our lysates are made using RIPA buffer to which we add a protease inhibitor cocktail and phosphatase inhibitor cocktail (ratio: 300:100:10). This means that the protein of interest is denatured. If you require a native form of the protein please use the live cell version. Please refer to our lysis protocol for further details on how our lysates are prepared.

User storage instructions: Lyophilizate may be stored at 4°C. After reconstitution, store at -20°C for short-term storage or -80°C for long-term storage.

This product is subject to limited use licenses from The Broad Institute and ERS Genomics Limited, and is developed with patented technology. For full details of the limited use licenses and relevant patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "1Kit": { "sellingSize": "1 Kit", "publicAssetCode":"ab263348-1Kit", "assetComponentDetails": [ { "size":"1 x 100 µg", "name":"Human SLC12A9 knockout HeLa cell lysate", "number":"AB263348-CMP01", "productcode":"" }, { "size":"1 x 100 µg", "name":"Human wild-type HeLa cell lysate", "number":"AB263348-CMP02", "productcode":"" } ] } } }

Properties and storage information

Gene name
SLC12A9
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

SLC12A9 also known as CCC9 is part of the cation-chloride cotransporter family. It is a protein with an approximate mass of 120 kDa. This transporter is involved in moving ions across cell membranes particularly sodium potassium and chloride ions playing a significant role in maintaining cellular homeostasis. SLC12A9 is expressed in various tissues including the kidney and brain suggesting its importance across different physiological systems.
Biological function summary

The protein facilitates ion transport within cells contributing to osmoregulation and volume control. Although SLC12A9 is not a central part of any known large protein complex its ion transport functionality indicates it might interact with other membrane proteins involved in similar regulatory roles. This interaction helps modulate cell volume and osmolality which influences cell survival and function.

Pathways

SLC12A9 plays a role in the cellular signaling and homeostasis pathways. It is particularly associated with the WNK (With No Lysine) kinases-pathway which regulates electrolyte balance and blood pressure. In this context SLC12A9 has relations with other transporters like NKCC1 and KCC2 which also participate in the same ion transport and regulatory processes indicating cooperative interactions in maintaining cellular ionic balance.

Several studies have linked SLC12A9 to hypertension due to its role in regulating blood pressure via ion transport. Additionally research suggests its potential involvement in neurological disorders given its expression in brain tissues. Mutations or dysregulation of SLC12A9 could affect other related proteins such as WNK kinases contributing to these pathologies by altering ion transport dynamics and impacting overall cellular function.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com